Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-06-17T05:04:23.096Z Has data issue: false hasContentIssue false

22 - Laboratory Diagnosis of Inborn Errors of Metabolism

from SECTION IV - METABOLIC LIVER DISEASE

Published online by Cambridge University Press:  18 December 2009

Devin Oglesbee Ph.D.
Affiliation:
Fellow in Molecular Genetics, Mayo Clinic, Rochester, Minnesota
Piero Rinaldo M.D., Ph.D.
Affiliation:
Professor of Pathology and Pediatrics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
Frederick J. Suchy
Affiliation:
Mount Sinai School of Medicine, New York
Ronald J. Sokol
Affiliation:
University of Colorado, Denver
William F. Balistreri
Affiliation:
University of Cincinnati
Get access

Summary

Inborn errors of metabolism are recognized with increasing frequency as a cause of disease manifestations in every organ and at every life interval from the fetus to the geriatric patient [1]. Yet their collective incidence is often underestimated, and diagnostic errors often occur, leading to devastating consequences for patients and their families [2]. Among an increasing number of single-gene disorders that are currently recognized, inborn errors of the intermediate metabolism of amino acids, carbohydrates, and fatty acids deserve special attention. The majority of these diseases have been identified within the past 30 years, primarily through the detection of endogenous metabolites abnormally accumulating in biologic fluids [3]. This chapter focuses predominantly on the laboratory diagnosis of three major groups of metabolic diseases: organic acidurias, congenital lactic acidemias, and disorders of fatty acid transport and oxidation. Aspects of urea cycle defects and amino acid disorders are covered to a lesser extent.

The inborn errors listed in Table 22.1 share a common natural history, which is the occurrence of either acute life-threatening illness in early infancy or unexplained developmental delay with intercurrent episodes of metabolic decompensation in later childhood. Unfortunately, the clinical presentations of these diseases are often attributed to a variety of other causes (Table 22.2). Indeed, once a patient is properly diagnosed with a metabolic condition, it is not uncommon to find retrospectively that a sibling within the same family presented with similar symptoms but had passed away without a precise diagnosis.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Scriver CR. Foreword. In: Blau, N, Duran, M, Blaskovics, M E., eds. Physician's guide to the laboratory diagnosis of metabolic diseases. 2nd ed. Berlin: Springer-Verlag, 2003:v–xii.CrossRefGoogle Scholar
Hoffman, M. Scientific sleuths solve a murder mystery. Science 1991;254:931.CrossRefGoogle ScholarPubMed
Beaudet AL, Scriver CR, Beaudet AL, et al. Genetics and biochemistry of variant human phenotypes. In: Scriver, C R, Beaudet, A L, Sly, W S., eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:3–45.Google Scholar
Hostetler, M A, Arnold, G L, Mooney, R. Hypoketotic hypoglycemic coma in a 21 month old. Ann Emerg Med 1999;34:394–8.CrossRefGoogle Scholar
Fernandes, J, Saudubray, J M, Berghe, G, eds. Inborn metabolic diseases. Diagnosis and treatment. 3rd ed. Berlin: Springer-Verlag, 2000.CrossRefGoogle Scholar
Blau, N, Hoffman, G F, LeonardJ, et al J, et al., eds. Physician's guide to the treatment and follow-up of metabolic diseases. Berlin: Springer-Verlag, 2006.CrossRefGoogle Scholar
Odievre, M. Clinical presentation of metabolic liver disease. J Inherit Metab Dis 1991;14:526–37.CrossRefGoogle ScholarPubMed
Saudubray, J M, Nassogne, M C, Lonlay, P. Clinical approach to inherited metabolic disorders in neonates: an overview. Semin Neonatol 2002;7:3–15.CrossRefGoogle ScholarPubMed
Saudubray JM, Ogier de Baulny H, Charpentier C. Clinical approach to inherited metabolic disorders. In: Fernandes, J, Saudubray, J M, Berghe, G. Inborn metabolic diseases. Diagnosis and treatment. 3rd ed. Berlin: Springer-Verlag, 2000:3–41.CrossRefGoogle Scholar
Saudubray JM, Charpentier C. Clinical phenotypes: diagnosis algorithms. In: Scriver, C R, Beaudet, A L, Sly, W S., eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:1327–403.Google Scholar
Saudubray, J M, Martin, D, Poggi-Travert, F. Clinical presentations of inherited mitochondrial fatty acid oxidation disorders: an update. Int Pediatr 1997;12:34–40.Google Scholar
Hommes, F. Techniques in diagnostic human biochemical genetics – a laboratory manual. New York: Wiley-Liss, 1991.Google Scholar
Blau, N, Duran, M, Blaskovics, M E., eds. Physician's guide to the laboratory diagnosis of metabolic diseases. 2nd ed. Berlin: Springer-Verlag, 2003.CrossRefGoogle Scholar
Wraith, J E. Diagnosis and management of inborn errors of metabolism. Arch Dis Child 1989;64:1410–15.CrossRefGoogle ScholarPubMed
Johnson JL, Wadman SK. Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver, C R, Beaudet, A L, Sly, W S., eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:3163–77.Google Scholar
Rinaldo, P, Yoon, H R, Yu, C. Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders. Semin Perinatol 1999;23:204–10.CrossRefGoogle ScholarPubMed
ACMG Laboratory Practice Committee. Standards and guidelines for clinical genetics laboratories. 2006 ed. Bethesda, Md.: American College of Medical Genetics, 2006:F.7.7.3.7.
Goodman, S I, Markey, S P. Diagnosis of organic acidemias by gas chromatography–mass spectrometry. New York: Alan R Liss, 1981.Google ScholarPubMed
Chalmers, R A, Lawson, A M. Organic acids in man. Analytical chemistry, biochemistry and diagnosis of the organic acidurias. London: Chapman & Hall, 1982.Google Scholar
Sweetman, L. Organic acid analysis. In: Hommes, F, ed. Techniques in diagnostic human biochemical genetics – a laboratory manual. New York: Wiley-Liss, 1991:143–76.Google Scholar
Lehotay, D C, Clarke, J T R. Organic acidurias and related abnormalities. Crit Rev Clin Lab Sci 1995;32:377–429.CrossRefGoogle ScholarPubMed
Hoffman GF, Feyh P. Organic acid analysis. In: Blau, N, Duran, M, Blaskovics, M E. eds. Physician's guide to the laboratory diagnosis of metabolic diseases. 2nd ed. Berlin: Springer-Verlag, 2003:27–44.CrossRefGoogle Scholar
Burlina, A B, Bonafé, L, Zacchello, F. Clinical and biochemical approach to the neonate with a suspected inborn error of amino acid and organic acid metabolism. Semin Perinatol 1999;23:162–73.CrossRefGoogle ScholarPubMed
Sweetman L, Williams JC. Branched chain organic acidurias. In: Scriver, C R, Beaudet, A L, Sly, W S., eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:2125–63.Google Scholar
Millington DS, Chace DH, Hillman SL, et al. Diagnosis of metabolic disease. In: Matsuo, T, Caprioli, R M, Gross, M L., eds. Biological mass spectrometry: present and future. New York: Wiley, 1994:559–79.Google Scholar
Rashed, M S, Bucknall, M P, Little, D. Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal results. Clin Chem 1997;43:1129–41.Google Scholar
Rinaldo, P, O'Shea, J J, Coates, P M. Medium chain acyl-CoA dehydrogenase deficiency: diagnosis by stable isotope dilution analysis of urinary n-hexanoylglycine and 3-phenylpropionylglycine. N Engl J Med 1988;319:1308–13.CrossRefGoogle ScholarPubMed
Yamaguchi, S, Shimuzu, N, Orii, T. Prenatal diagnosis of Glutaric aciduria type II due to electron transfer flavoprotein (β-subunit) deficiency and the time course of metabolite excretion after birth. Pediatr Res 1991;30:439–43.CrossRefGoogle Scholar
Sue, C M, Hirano, M, DiMauro, S. Neonatal presentations of mitochondrial metabolic disorders. Semin Perinatol 1999;32:113–24.CrossRefGoogle Scholar
Vassault A, Bonnefont JP, Specola N, et al. Lactate, pyruvate, and ketone bodies. In: Hommes, F, ed. Techniques in diagnostic human biochemical genetics – a laboratory manual. New York: Wiley-Liss, 1991:285–308.Google Scholar
Smeitink J, van den Heuvel B, Trijbels F, et al. Mitochondrial energy metabolism. In: Blau, N, Duran, M, Blaskovics, M E., eds. Physician's guide to the laboratory diagnosis of metabolic diseases. 2nd ed. Berlin: Springer-Verlag, 2003:519–36.CrossRefGoogle Scholar
Robinson, B H, MacMillan, H, Petrova-Benedict, R. Variable clinical presentation in patients with defective E1 component of the pyruvate dehydrogenase complex. J Pediatr 1987;111:525–33.CrossRefGoogle ScholarPubMed
Robinson BH. Lactic academia: disorders of pyruvate carboxylase and pyruvate dehydrogenase complex. In: Scriver, C R, Beaudet, A L, Sly, W S., eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:2275–95.Google Scholar
Leonard, J V, Schapira, A H V. Mitochondrial respiratory chain disorders. I: mitochondrial DNA defects. Lancet 2000;355:299–304.CrossRefGoogle ScholarPubMed
Robinson, B H, Taylor, J, Sherwood, W G. The genetic heterogeneity of lactic acidosis: occurrence of recognizable inborn errors of metabolism in a pediatric population with lactic acidosis. Pediatr Res 1980;14:956–62.CrossRefGoogle Scholar
Coude, F X, Ogier, H, Marsac, C. Secondary citrullinemia with hyperammonemia in four neonatal cases of pyruvate carboxylase deficiency. Pediatrics 1981;68:914.Google ScholarPubMed
Munnich, A, Saudubray, J-M, Taylor, J. Congenital lactic acidosis, α-ketoglutaric aciduria and variant form of maple syrup urine disease due to a single enzyme defect: dihydrolipoyldehydrogenase deficiency. Acta Paediatr Scand 1982;71:167–71.CrossRefGoogle Scholar
Bonnefont, J P, Chretien, D, Rustin, P. Alpha-ketoglutarate dehydrogenase deficiency presenting as congenital lactic acidosis. J Pediatr 1992;121:255–8.CrossRefGoogle ScholarPubMed
Shih VE. Amino acid analysis. In: Blau, N, Duran, M, Blaskovics, M E., eds. Physician's guide to the laboratory diagnosis of metabolic diseases. 2nd ed. Berlin: Springer-Verlag, 2003:11–26.CrossRefGoogle Scholar
Tein, I. Neonatal metabolic myopathies. Semin Perinatol 1999;23:125–51.CrossRefGoogle ScholarPubMed
Pettersen, J E, Landaas, S, Eldjarn, L. The occurrence of 2-hydroxy butyric acid in urine from patients with lactic acidosis. Clin Chim Acta 1973;48:213–19.CrossRefGoogle Scholar
Landaas, S, Pettersen, J E. Clinical conditions associated with urinary excretion of 2-hydroxy butyric acid. Scand J Clin Lab Invest 1975;35:259–66.CrossRefGoogle Scholar
Chalmers, R A. Organic acids in urine of patients with congenital lactic acidosis: an aid to differential diagnosis. J Inherit Metab Dis 1984;7 Suppl 1:79–89.CrossRefGoogle ScholarPubMed
Rinaldo, P, Marcon, M, Dussini, N. Urinary organic acids in inherited disorders of mitochondrial metabolism: presumptive differential diagnosis of lactic acidoses by gas chromatographymass spectrometry. Perspect Inherit Metab Dis 1985;6:53–63.Google Scholar
Wolf B. Disorders of biotin metabolism. In: Scriver, C R, Beaudet, A L, Sly, W S., eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:3935–62.Google Scholar
Bourgeron, T, Rustin, P, Chretien, D. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995;11:144–9.CrossRefGoogle ScholarPubMed
Bennett, M J, Sherwood, W G, Gibson, K M. Secondary inhibition of multiple NAD-requiring dehydrogenases in respiratory chain complex I deficiency: possible metabolic markers for the primary defect. J Inherit Metab Dis 1993;16:560–2.CrossRefGoogle ScholarPubMed
Eaton, S, Bartlett, K, Pourfarzam, M. Mammalian mitochondrial β-oxidation. Biochem J 1996;320:345–57.CrossRefGoogle ScholarPubMed
McGarry, J D, Foster, D W. Regulation of hepatic fatty acid oxidation and ketone body production. Ann Rev Biochem 1980;49:395–420.CrossRefGoogle ScholarPubMed
Bennett, M J, Rinaldo, P, Strauss, A W. Inborn errors of mitochondrial fatty acid oxidation. Crit Rev Clin Lab Sci 2000;37:1–44.CrossRefGoogle ScholarPubMed
Nyhan WL, Barshop BA, Ozand PT. Disorders of fatty acid oxidation. In: Nyhan, W L, Barshop, B A, Ozand, P T, eds. Atlas of metabolic diseases. London: Hodder Arnold, 2005:239–99.Google Scholar
Rinaldo, P, Stanley, C A, Sanchez, L A. Sudden neonatal death in carnitine transporter deficiency. J Pediatr 1997;131:304–5.CrossRefGoogle ScholarPubMed
Chalmers, R A, Stanley, C A, English, N. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death. J Pediatr 1997;131:220–5.CrossRefGoogle ScholarPubMed
Smelt, A H M, Poorthuis, BJHM, Onkenhout, W. Very long chain acyl-coenzyme A dehydrogenase deficiency with adult onset. Ann Neurol 1998;43:540–4.CrossRefGoogle ScholarPubMed
Raymond, K, Bale, A E, Barnes, C A. Medium-chain acyl-CoA dehydrogenase deficiency: sudden and unexpected death of a 45 year old woman. Genet Med 1999;1:293–4.CrossRefGoogle ScholarPubMed
Al Odaib, A, Shneider, B L, Bennett, M J. A defect in the transport of long-chain fatty acids associated with acute liver failure. N Engl J Med 1998;339:1752–7.CrossRefGoogle Scholar
Boles, R G, Buck, E A, Blitzer, M G. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem liver of 418 cases of sudden unexpected death in the first year of life. J Pediatr 1998;132:924–33.CrossRefGoogle ScholarPubMed
Patel, J S, Leonard, J V. Ketonuria and medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 1995;18:98–9.CrossRefGoogle ScholarPubMed
Bennett, M J, Weinberger, M J, Kobori, J A. Mitochondrial short-chain L-3-hydroxybutyryl-CoA dehydrogenase deficiency: a new defect of fatty acid oxidation. Pediatr Res 1996;39:185–8.CrossRefGoogle Scholar
Duran M. Disorders of mitochondrial fatty acid oxidation and ketone body handling. In: Blau, N, Duran, M, Blaskovics, M E., eds. Physician's guide to the laboratory diagnosis of meta-bolic diseases. 2nd ed. Berlin: Springer-Verlag, 2003:309–34.CrossRefGoogle Scholar
Rinaldo, P, Raymond, K, Al Odaib, A. Fatty acid oxidation disorders: clinical and biochemical features. Curr Opin Pediatr 1998;10:615–21.CrossRefGoogle ScholarPubMed
Lehnert, W, Ruitenbeek, W. Ethylmalonic aciduria associated with progressive neurological disease and partial cytochrome C oxidase deficiency. J Inherit Metab Dis 1993;16:557–9.CrossRefGoogle ScholarPubMed
Christensen, E, Brandt, N J, Schmalbruch, H. Muscle cyto-chrome C oxidase deficiency accompanied by a urinary organic acid pattern mimicking multiple acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 1993;16:553–6.CrossRefGoogle Scholar
Burlina, A B, Dionisi-Vici, C, Bennett, M J. A new encephalopathy with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts. J Pediatr 1994;124:79–86.CrossRefGoogle ScholarPubMed
Bhala, A, Willi, S M, Rinaldo, P. The emerging clinical and biochemical picture of short-chain acyl-CoA dehydrogenase deficiency. J Pediatr 1995;126:910–15.CrossRefGoogle Scholar
Corydon, M J, Gregersen, N, Lehnert, W. Ethylmalonic aciduria is associated with an amino acid variant (G209S) of short-chain acyl-coenzyme A dehydrogenase (SCAD). Pediatr Res 1996;39:1059–66.CrossRefGoogle Scholar
Gregersen, N, Winter, V, Corydon, M J. Identification of four new mutations in the short-chain acyl-CoA dehydrogenase (SCAD) gene in two patients: one of the variant alleles, 511CT, is present at an unexpectedly high frequency in the general population, as was the case for 625GA, together conferring susceptibility to ethylmalonic aciduria. Hum Mol Genet 1998;7:619–27.CrossRefGoogle Scholar
Stanley, C A, DeLeeuw, S, Coates, P M. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol 1991;30:709–16.CrossRefGoogle ScholarPubMed
Costa, C G, Dorland, L, Holwerda, U. Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid β-oxidation disorders. Clin Chem 1998;44:463–71.Google ScholarPubMed
Jones, P M, Quinn, R, Fennessey, P. An improved method for measuring serum or plasma free 3-hydroxy-fatty acids using stable isotope dilution gas chromatography-mass spectrometry and its utility for the study of disorders of mitochondrial fatty acid β-oxidation. Clin Chem 2000;46:149–55.Google ScholarPubMed
McLafferty, F W. Tandem mass spectrometry. Science 1981;214:280–7.CrossRefGoogle ScholarPubMed
Fenn, J B, Mann, M, Meng, C K. Electrospray ionization for mass spectrometry of large molecules. Science 1989;246:64–71.CrossRefGoogle Scholar
Magera, M J, Lacey, J M, Casetta, B. A method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clin Chem 1999;45:1517–22.Google ScholarPubMed
Levy, H L. Newborn screening by tandem mass spectrometry: a new era [Editorial]. Clin Chem 1998;44:2401–2.Google Scholar
Chace, D H, DiPerna, J C, Naylor, E W. Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millennium. Acta Pediatr 1999;88:45–7.CrossRefGoogle ScholarPubMed
Andresen, B S, Bross, P, Udvari, S. The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype?Hum Mol Genet 1997;6:695–707.CrossRefGoogle ScholarPubMed
Brusilow SW, Horwich AL. Urea cycle enzymes. In: Scriver, C R, Beaudet, A L, Sly, W S., eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001: 1909–63.Google Scholar
Rowe, P C, Newman, S L, Brusilow, S W. Natural history of symptomatic partial ornithine transcarbamylase deficiency. N Engl J Med 1986;314:541–7.CrossRefGoogle ScholarPubMed
Leonard JV. Disorders of the urea cycle. In: Fernandes, J, Saudubray, J M, Berghe, G. Inborn metabolic diseases. Diagnosis and treatment. 3rd ed. Berlin: Springer-Verlag, 2000:213–22.CrossRefGoogle Scholar
Bachmann, C, Colombo, J P. Acid-base status and plasma glutamine in patients with hereditary urea cycle disorders. In: Soeters, P B, Wilson, J H P, Meijer, A J. Advances in ammonia metabolism and hepatic encephalopathy. Amsterdam: Elsevier, 1988:72–8.Google Scholar
Bachmann, C. Satellite meeting on advances in inherited urea cycle disorders. Recent results – new questions. J Inherit Metab Dis 1998;21 Suppl 1:1–5.CrossRefGoogle Scholar
Chuang, D T, Shih, V E. Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver, C R, Beaudet, A L, Sly, W S. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:1971–2006.Google Scholar
Matthews, D E, Ben-Galim, E, Haymond, M W. Alloisoleucine formation in maple syrup urine disease: isotopic evidence for the mechanism. Pediatr Res 1980;14:854–7.Google ScholarPubMed
Hamosh A, Johnston MV. Nonketotic hyperglycinemia. In: Scriver, C R, Beaudet, A L, Sly, W S. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:2065–78.Google Scholar
Tada, K, Narisawa, K. Non-ketotic hyperglycinemia: clinical and biochemical aspects. Eur J Pediatr 1987;146:221–7.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×